Baudax Bio, Inc, a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings.

Source: https://www.americanbankingnews.com/2023/08/10/baudax-bio-bxrx-to-release-quarterly-earnings-on-friday.html

Finally, Alyeska Investment Group L.P. acquired a new position in Baudax Bio in the first quarter valued at approximately $814,000.

Source: https://www.dailypolitical.com/2023/03/03/short-interest-in-baudax-bio-inc-nasdaqbxrx-declines-by-47-6.html

Renaissance Technologies LLC grew its position in Baudax Bio by 117.9% during the 1st quarter.

Source: https://www.dailypolitical.com/2023/01/20/baudax-bio-inc-nasdaqbxrx-short-interest-down-28-9-in-december.html

Warberg Asset Management LLC boosted its stake in Baudax Bio by 682.6% in the 3rd quarter.

Source: https://www.americanbankingnews.com/2023/05/11/baudax-bio-inc-nasdaqbxrx-sees-significant-growth-in-short-interest.html